Short Interest in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Increases By 6.4%

Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 894,500 shares, a growth of 6.4% from the January 15th total of 840,400 shares. Based on an average daily volume of 294,500 shares, […]

Related Keywords

,Nasdaq ,Topco Ltd ,Prelude Capital Management ,Mirabella Financial Services ,Charles Schwab Investment Management Inc ,Aligos Therapeutics Inc ,Aligos Therapeutics ,Get Free Report ,Capital Management ,Schwab Investment Management ,Financial Services ,Aligos Therapeutics Daily ,Nasdaq Algs ,Salgs ,Medical ,Stocks ,Options ,Put ,Call ,